Jae-Lyun Lee, MD, of the Asan Medical Center, Seoul, South Korea, speaks about the promising results of gemcitabine-oxaliplatin (GemOx) for advanced urothelial carcinoma (UC) to date, and discusses future directions for the treatment of cisplatin-unfit advanced UC. This video was filmed at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA.

By choosing to continue, you are confirming that you are a healthcare professional

VJO needs the contact information you provide to inform you about our latest oncology news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

Please enter your details if you would like to receive the latest oncology news and updates